Cutting-Edge Diabetes Conference, ATTD, to Present Advanced Technologies & Treatments
Every
10 seconds a person dies from diabetes and every year,
3 million do. Every year there are
6 million new sufferers and by 2025, there might be 12 million. Entrepreneurs are racing against the statistics to develop effective devices and systems to treat and prevent diabetes.
The 4th International Advanced Technologies and Treatment for Diabetes Conference (London, February 16-19, 2011), will reveal these latest technologies to researchers, clinicians and general practitioners in all fields of diabetes so that they may study, appraise and discuss them. Since the practical implementation of any groundbreaking invention is in their hands, it is imperative that they be at the forefront of this constantly evolving discipline.
Recognizing ATTD as
the vanguard diabetes technology meeting, key opinion leaders will present a rich scientific programme on key topics and inventions such as informatics in the service of medicine, implantable pumps and sensors, glycemic control in the hospital, glucose sensors and artificial pancreas, as well as new integrated systems for insulin delivery.
Another essential topic is the wide use of glucose sensors in the pediatric age group. To help establish standards of care for these patients, the European Society for Paediatric Endocrinology (ESPE), the International Society of Pediatric and Adolescent Diabetes (ISPAD) and Pediatric Endocrine Society (PES), have formed the Loop Club. Just before ATTD, the Club will hold a
Consensus Workshop (London, February 14-16, 2011), prepare a consensus statement, and present it during the conference.
For an overview of the most important articles published on diabetes technology between July 2009 and June 2010, ATTD participants will receive a free copy of the latest
Yearbook on Advanced Technologies & Treatments in Diabetes (2010).
Diabetes is now the fourth biggest cause of death and half of sufferers do not know they have it. It is estimated that diabetes accounts for 5% to 10% of most nations' health budgets. If more money were spent on early detection of diabetes and diabetes prevention, the economic savings would be massive. It is hoped that by disseminating information and advocating the importance of early detection and prevention,
ATTD participants can and will make a difference! For more information about the ATTD 2011 Conference, please email attd@kenes.com or visit the congress website: www.kenes.com/attd.